Avanti Biosciences is Biotechnology in United States that focus on Hyperammonemia syndrome business. Founded in 2009. They cover business area such as owner, operator, development, innovative therapy, patient, disease, efficient form, new chemical entity, natural product, Hyperinsulinemia and Hyperammonemia syndrome.
2009
( 15 years old in 2024 )
Hyperammonemia Syndrome
-
25 Health Sciences Drive
Mail Box 202
NY 11790
United States
Private
owneroperatordevelopmentinnovative therapypatientdiseaseefficient formnew chemical entitynatural productHyperinsulinemia and Hyperammonemia syndrome
* We use standard office opening hours in near Avanti Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Avanti Biosciences is Biotechnology business from United States that founded in 2009 (15 years old in 2024), Avanti Biosciences business is focusing on Hyperammonemia Syndrome.
Avanti Biosciences headquarter office and corporate office address is located in 25 Health Sciences Drive Mail Box 202 NY 11790 United States.
Avanti Biosciences was founded in United States.
In 2024, Avanti Biosciences is currently focus on Hyperammonemia syndrome sector.
Above is snippet of Google Trends for "Hyperammonemia syndrome" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Avanti Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
